(HealthDay)—Defitelio (defibrotide sodium) has been approved by the U.S. Food and Drug Administration to treat a rare, but usually fatal liver disease that affects some people who have had a stem cell transplant.
Mar 30, 2016
0
3
Key opinions leaders in the field of haematopoetic stem cell transplantation (HSCT) will address the role of Cyclophosphamide, an anti-cancer chemotherapy drug, during the 42nd Annual Meeting of the European Society for Blood ...
Mar 30, 2016
0
0
A new study demonstrates that iPSC have the potential to differentiate into multiple lineages of functional lymphocytes, including CD4+ T cells, B cells, and natural killer cells, without bias. The ability to generate truly ...
Mar 28, 2016
0
1
Scientists at Virginia Commonwealth University have developed computer models that can simulate the recovery of the immune system in patients undergoing stem cell transplants. In two recent studies, they reinforce the potential ...
Mar 17, 2016
0
4
Australian scientists have developed a new method for harvesting stem cells, which is less invasive and reduces side effects for donors.
Mar 15, 2016
0
154
People with leukaemia could be helped by new research that sheds light on how the body produces its blood supply.
Mar 10, 2016
0
1
Aplastic anaemia is a rare, and potentially fatal, disease of the blood, by which the bone marrow is unable to generate blood cells at the appropriate pace. Many forms of aplastic anaemia share an important link with the ...
Feb 24, 2016
1
1
Scientists from The Scripps Research Institute (TSRI) have identified a molecule that appears to be a cause of autoimmune diseases such as lupus. Elevated levels of the molecule allow self-reactive immune cells to escape ...
Feb 22, 2016
0
3562
A study led by scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has uncovered a key player contributing to the maintenance of hematopoietic stem cells ...
Feb 17, 2016
0
5
ONC201, an anti-cancer drug that triggers cell death in various tumor types, may have clinical potential for some blood cancers including mantel cell lymphoma (MCL) and acute myeloid leukemia (AML), according to a recent ...
Feb 16, 2016
0
3
